Literature DB >> 23660001

Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.

Francesca Ficara1, Laura Crisafulli, Chenwei Lin, Masayuki Iwasaki, Kevin S Smith, Luca Zammataro, Michael L Cleary.   

Abstract

The capacity of the hematopoietic system to promptly respond to peripheral demands relies on adequate pools of progenitors able to transiently proliferate and differentiate in a regulated manner. However, little is known about factors that may restrain progenitor maturation to maintain their reservoirs. Conditional knockout mice for the Pbx1 proto-oncogene have a significant reduction in lineage-restricted progenitors in addition to a profound defect in hematopoietic stem cell (HSC) self-renewal. Through analysis of purified progenitor proliferation, differentiation capacity and transcriptional profiling, we demonstrate that Pbx1 regulates the lineage-specific output of multipotent and oligopotent progenitors. In the absence of Pbx1 multipotent progenitor (MPP) and common myeloid progenitor (CMP) pools are reduced due to aberrantly rapid myeloid maturation. This is associated with premature expression of myeloid differentiation genes and decreased maintenance of proto-oncogene transcriptional pathways, including reduced expression of Meis1, a Pbx1 dimerization partner, and its subordinate transcriptional program. Conversely, Pbx1 maintains the lymphoid differentiation potential of lymphoid-primed MPPs (LMPPs) and common lymphoid progenitors (CLPs), whose reduction in the absence of Pbx1 is associated with a defect in lymphoid priming that is also present in CMPs, which persistently express lymphoid and HSC genes underlying a previously unappreciated lineage promiscuity that is maintained by Pbx1. These results demonstrate a role for Pbx1 in restraining myeloid maturation while maintaining lymphoid potential to appropriately regulate progenitor reservoirs.

Entities:  

Keywords:  CLPs; CMPs; MPPs; Myeloid differentiation; Pbx1

Mesh:

Substances:

Year:  2013        PMID: 23660001      PMCID: PMC3711206          DOI: 10.1242/jcs.125435

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  43 in total

1.  Abnormalities of caudal pharyngeal pouch development in Pbx1 knockout mice mimic loss of Hox3 paralogs.

Authors:  Nancy R Manley; Licia Selleri; Andrea Brendolan; Julie Gordon; Michael L Cleary
Journal:  Dev Biol       Date:  2004-12-15       Impact factor: 3.582

2.  Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.

Authors:  C P Chang; Y Jacobs; T Nakamura; N A Jenkins; N G Copeland; M L Cleary
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.

Authors:  Donald Metcalf; Aleksandar Dakic; Sandra Mifsud; Ladina Di Rago; Li Wu; Stephen Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.

Authors:  Omer H Yilmaz; Riccardo Valdez; Brian K Theisen; Wei Guo; David O Ferguson; Hong Wu; Sean J Morrison
Journal:  Nature       Date:  2006-04-05       Impact factor: 49.962

6.  A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny.

Authors:  Andrea Brendolan; Elisabetta Ferretti; Valentina Salsi; Kelvin Moses; Susan Quaggin; Francesco Blasi; Michael L Cleary; Licia Selleri
Journal:  Development       Date:  2005-07       Impact factor: 6.868

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 8.  Hox cofactors in vertebrate development.

Authors:  Cecilia B Moens; Licia Selleri
Journal:  Dev Biol       Date:  2006-03-03       Impact factor: 3.582

9.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

10.  FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.

Authors:  Zuzana Tothova; Ramya Kollipara; Brian J Huntly; Benjamin H Lee; Diego H Castrillon; Dana E Cullen; Elizabeth P McDowell; Suzan Lazo-Kallanian; Ifor R Williams; Christopher Sears; Scott A Armstrong; Emmanuelle Passegué; Ronald A DePinho; D Gary Gilliland
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

View more
  18 in total

1.  Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.

Authors:  A Sharma; H Yun; N Jyotsana; A Chaturvedi; A Schwarzer; E Yung; C K Lai; F Kuchenbauer; B Argiropoulos; K Görlich; A Ganser; R K Humphries; M Heuser
Journal:  Leukemia       Date:  2014-05-20       Impact factor: 11.528

2.  The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.

Authors:  Jeffrey S Gaynes; Leslie M Jonart; Edward A Zamora; Jordan A Naumann; Nathan P Gossai; Peter M Gordon
Journal:  Haematologica       Date:  2016-12-29       Impact factor: 9.941

3.  TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.

Authors:  A Willer; J S Jakobsen; E Ohlsson; N Rapin; J Waage; M Billing; L Bullinger; S Karlsson; B T Porse
Journal:  Leukemia       Date:  2014-10-28       Impact factor: 11.528

4.  Estrogen receptor alpha signaling promotes Sle1-induced loss of tolerance and immune cell activation and is responsible for sex bias in B6.Sle1 congenic mice.

Authors:  Shayla D Yoachim; Jenny S Nuxoll; Kimberly K Bynoté; Karen A Gould
Journal:  Clin Immunol       Date:  2015-04-07       Impact factor: 3.969

5.  The PBX1 lupus susceptibility gene regulates CD44 expression.

Authors:  Yuxin Niu; Mayami Sengupta; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Mol Immunol       Date:  2017-03-01       Impact factor: 4.407

6.  Spleen hypoplasia leads to abnormal stress hematopoiesis in mice with loss of Pbx homeoproteins in splenic mesenchyme.

Authors:  Rediet Zewdu; Maurizio Risolino; Alexandru Barbulescu; Pradeep Ramalingam; Jason M Butler; Licia Selleri
Journal:  J Anat       Date:  2016-04-14       Impact factor: 2.610

7.  Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.

Authors:  Mark W Woodcroft; Kyster Nanan; Patrick Thompson; Kathrin Tyryshkin; Steven P Smith; Robert K Slany; David P LeBrun
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Prep1 (pKnox1) regulates mouse embryonic HSC cycling and self-renewal affecting the Stat1-Sca1 IFN-dependent pathway.

Authors:  Livia Modica; Giorgio Iotti; Annalisa D'Avola; Francesco Blasi
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

9.  Loss of the Homeodomain Transcription Factor Prep1 Perturbs Adult Hematopoiesis in the Bone Marrow.

Authors:  Kentaro Yoshioka; Akihisa Oda; Chihiro Notsu; Takafumi Ohtsuka; Yasuhiro Kawai; Sadafumi Suzuki; Takuro Nakamura; Yo Mabuchi; Yumi Matsuzaki; Ryo Goitsuka
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

10.  Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.

Authors:  Lynn Quek; Georg W Otto; Catherine Garnett; Ludovic Lhermitte; Dimitris Karamitros; Bilyana Stoilova; I-Jun Lau; Jessica Doondeea; Batchimeg Usukhbayar; Alison Kennedy; Marlen Metzner; Nicolas Goardon; Adam Ivey; Christopher Allen; Rosemary Gale; Benjamin Davies; Alexander Sternberg; Sally Killick; Hannah Hunter; Paul Cahalin; Andrew Price; Andrew Carr; Mike Griffiths; Paul Virgo; Stephen Mackinnon; David Grimwade; Sylvie Freeman; Nigel Russell; Charles Craddock; Adam Mead; Andrew Peniket; Catherine Porcher; Paresh Vyas
Journal:  J Exp Med       Date:  2016-07-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.